Qsymia, Belviq Make Progress With Aetna, But Coverage Remains Long-Term Challenge
Executive Summary
Aetna has issued a revised clinical policy bulletin that includes Qsymia and Belviq among the drugs it considers to be “medically necessary weight reduction medications” when a series of criteria are met.